Neurotype Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $329K

  • Investors
  • 4

Neurotype General Information

Description

Developer of brain sensor and software platform intended to help people overcome environmental triggers for addictive behaviors like drug use and overeating. The company's device objectively detects drug cravings in patients undergoing treatment for opioid use disorder and provides strategies to combat cravings, enabling improved mental and behavioral healthcare.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 4610 East Lake Street
  • Suite 306
  • Minneapolis, MN 55406-2364
  • United States
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 4610 East Lake Street
  • Suite 306
  • Minneapolis, MN 55406-2364
  • United States

Neurotype Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotype Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 01-Oct-2023 $329K Completed Product Development
10. Grant 01-Jul-2023 Completed Product Development
9. Grant 19-Oct-2022 Completed Product Development
8. Grant 10-Oct-2022 Completed Product Development
7. Grant 28-Feb-2022 Completed Product Development
6. Accelerator/Incubator 15-Apr-2021 Completed Startup
5. Grant 15-Sep-2020 Completed Product Development
4. Grant 15-Jul-2020 Completed Startup
3. Accelerator/Incubator 01-Jan-2020 $405K $405K Completed Startup
2. Grant 15-Dec-2019 $10K Completed Startup
To view Neurotype’s complete valuation and funding history, request access »

Neurotype Patents

Neurotype Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12343157-B2 Assessing motivated attention with cue reactivity Active 14-Apr-2020
US-20210315508-A1 Assessing motivated attention with cue reactivity Active 14-Apr-2020

Neurotype Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotype Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Minnesota Department of Employment and Economic Development Government
National Institutes of Health Government
National Institute on Drug Abuse (NIDA) Government
Yale University University
To view Neurotype’s complete investors history, request access »

Neurotype FAQs

  • When was Neurotype founded?

    Neurotype was founded in 2019.

  • Where is Neurotype headquartered?

    Neurotype is headquartered in Minneapolis, MN.

  • What is the size of Neurotype?

    Neurotype has 4 total employees.

  • What industry is Neurotype in?

    Neurotype’s primary industry is Monitoring Equipment.

  • Is Neurotype a private or public company?

    Neurotype is a Private company.

  • What is Neurotype’s current revenue?

    The current revenue for Neurotype is .

  • How much funding has Neurotype raised over time?

    Neurotype has raised $460K.

  • Who are Neurotype’s investors?

    Minnesota Department of Employment and Economic Development, National Institutes of Health, National Institute on Drug Abuse (NIDA), and Yale University have invested in Neurotype.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »